CPIX Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the acquisition, development and commercialization of branded prescription products. Its target markets are hospital acute care and gastroenterology.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2009
Outstanding shares:  14,809,628
Average volume:  11,739,262
Market cap:   $62,496,630
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    230770109
ISIN:        US2307701092
Valuation   (See tab for details)
PE ratio:   -125.03
PB ratio:   1.46
PS ratio:   1.65
Return on equity:   -1.16%
Net income %:   -1.43%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy